Oculogica: Funding, Investors & Team (Oct 2026)
Oculogica is a company that focuses on creating medical devices for neuro-diagnostic purposes, specifically in the areas of brain injury, concussion, and eye-tracking. Their EyeBOX device is the only FDA-approved test for diagnosing concussions without needing baseline data or individual calibration, ensuring objective results that are not influenced by the patient. The company was founded in 2013 and is located in New York City.
Oculogica has raised $13.6M across 3 funding rounds on record, the most recent an undisclosed round of $7.6M announced in May 2024.
That round is in line with the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Oculogica Company Profile and Key Stats
Latest funding round on record: May 2024.
Oculogica Funding Rounds
Oculogica raised $2.0M in an undisclosed round announced in May 2021.
1.1 years later, a Debt Financing of $4.0M was announced in Jun 2022.
1.9 years later, an undisclosed round of $7.6M was announced in May 2024.
Oculogica Founders and Leadership Team
No contact details are on record for this team yet.
Oculogica Funding Compared to Other Biotechnology Startups
Oculogica's latest round of $7.6M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Oculogica in Biotechnology and New York
Companies Similar to Oculogica
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Oculogica Funding FAQs
What does Oculogica do?
Oculogica is a company that focuses on creating medical devices for neuro-diagnostic purposes, specifically in the areas of brain injury, concussion, and eye-tracking. Their EyeBOX device is the only FDA-approved test for diagnosing concussions without needing baseline data or individual calibration, ensuring objective results that are not influenced by the patient. The company was founded in 2013 and is located in New York City.
How much funding has Oculogica raised?
Oculogica has raised $13.6M across 3 rounds on record. The most recent is an undisclosed round of $7.6M announced in May 2024.
When did Oculogica last raise funding?
Oculogica's most recent funding round on record is an undisclosed round of $7.6M, announced in May 2024.
Who founded Oculogica?
FundedIQ lists Uzma Samadani (Founder) at Oculogica.
Who is the CEO of Oculogica?
Rosina Samadani is listed as CEO at Oculogica.
Where is Oculogica headquartered?
Oculogica is based in New York, United States.
How many employees does Oculogica have?
Oculogica is in the 11-50 employee band.
How does Oculogica's funding compare to other Biotechnology startups?
Oculogica's latest round of $7.6M is in line with the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Oculogica Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oculogica is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.